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1. Introduction 
Aflatoxins are a group of mycotoxins produced by certain species of Aspergillus. These 
molds grow on a variety of food and feed commodities and produce aflatoxins under 
appropriate temperature and humidity (Jay et al., 2005). Aflatoxin B1 (AFB1) is the most 
potent hepatocarcinogen of this group of mycotoxins. Aflatoxin M1 (AFM1) is a 
hydroxylated metabolite of AFB1 and is secreted in the milk of mammals that have eaten 
contaminated foods. AFM1 is also a hepatocarcinogen and is classified in Group 1 
(carcinogenic to humans) by the International Agency for Research on Cancer (IARC, 2002). 
Exposure to AFM1 through milk products is considered to be a serious public health 
problem. Several countries have established regulatory limits for AFM1 in raw milk and 
milk products, which vary from country to country. According to the Food and Agriculture 
Organization of the United Nations (FAO), there are 60 countries that have established 
regulatory limits for AFM1; the values vary from ND (not detectable) to 15 µg/L (FAO, 
2004). The two most prevalent limits are 0.05 µg/L (34 countries) and 0.5 µg/L (22 
countries). The European Community has set the maximum permitted level for AFM1 in 
infant formulae and follow-on formulae, including infant milk and follow-on milk, at 0.025 
µg/kg, and in raw milk and heat-treated milk at 0.05 µg/kg (European Commission, 2006). 
The U.S. regulatory limit for AFM1 is 0.5 µg/L (FAO, 2004). However, several countries, 
including Thailand, have not yet established regulatory limits for AFM1. The Notification of 
the Ministry of Public Health No. 265 – the law that regulates the quality of milk products in 
Thailand – only states that ‘‘…milk products may be contaminated with aflatoxins at a level that is 
not harmful to human health’’ (Ministry of Public Health, 2003). 
A national food consumption survey was conducted in Thailand during the years 2002–2004; 
18,746 participants were divided into five age groups (Groups 1–5): 0–3, >3–9, >9–19, >19–65, 
and >65 yr (National Bureau of Agricultural Commodity and Food Standards, 2006). The 
survey showed that the consumption amounts of four types of milk products – milk powder, 
school milk, commercial pasteurized milk, and UHT (ultra-high-temperature) milk – 
comprised approximately 93% of all milk products consumed by the Thai population 
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(National Bureau of Agricultural Commodity and Food Standards, 2006). In Thailand, in the 
morning on every school day, students in Grades 1–6 (age range, 6–12 yr) are served 
pasteurized milk (200 ml) provided by the School Milk Project (Ruangwises & Ruangwises, 
2009). Thailand is administratively divided into 76 provinces; the 45 provinces with the highest 
population were selected for milk sample collection. The purposes of this study were to 
investigate whether the concentrations of AFM1 in milk powder, school milk, commercial 
pasteurized milk, and UHT milk products consumed in Thailand are within the acceptable 
level for consumption, and to estimate the daily intake of AFM1 for the Thai population.  
2. Materials and methods  
2.1 Chemicals 
AFM1 reference standard (from Aspergillus flavus), trifluoroacetic acid, methylene chloride, n-
hexane, and silica gel 60 were purchased from Sigma-Aldrich (St. Louis, MO, USA). AflaM1TM 
immunoaffinity columns were purchased from Vicam (Nixa, MO, USA). Spherisorb ODS-2 
HPLC columns (5 m, 4.6  250 mm) and C18 Sep-Pak columns were obtained from Waters 
Corporation (Milford, MA, USA). Solvents (HPLC grade) – acetonitrile, methanol, isopropyl 
alcohol, and water – were obtained from Merck (Darmstadt, Germany). 
2.2 Milk sample collection and sample preparation 
Milk powder samples were purchased from supermarkets (2 samples/province), while 
school milk samples were collected from 180 elementary schools (4 schools/province). 
Commercial pasteurized and UHT milk samples were purchased from supermarkets (2 
samples each of pasteurized and UHT milk/province). All milk samples were collected 
between January 2007 and January 2008. Pasteurized milk samples were frozen at –20 °C 
until analysis (within one month from the manufacturing date). A total of 450 milk samples 
were analyzed in this study. 
Milk powder sample (31.25 g) was reconstituted in 200 ml of distilled water in a 250-ml 
volumetric flask, mixed well, and adjusted to 250 ml with distilled water (dilution 1: 8). 
Concentrations of fat, protein, and solid-not-fat (SNF) in reconstituted milk powder 
samples, analyzed using a MilkoScan 133B (Foss Electric, Hillerød, Denmark), were 4.12 ± 
0.36, 3.21 ± 0.08, and 8.59 ± 0.09 g/100 ml (n = 30), respectively. These milk compositions 
conformed with the Notification of the Ministry of Public Health No. 265, which states that 
fluid milk with full butter fat must contain fat, protein, and SNF of at least 3.2, 2.8, and 8.25 
g/100 ml, respectively (Ministry of Public Health, 2003). The densities of reconstituted and 
liquid milk samples were determined using 50 ml of milk sample. 
2.3 Extraction and determination of Aflatoxin M1 
AFM1 was extracted from milk samples using an AflaM1TM immunoaffinity column. The 
extraction procedure was according to the manufacturer’s recommendations, as previously 
described by Ruangwises & Ruangwises (2009). In brief, an aliquot of 50 ml of reconstituted 
milk powder or liquid milk sample was transferred to a 50-ml plastic centrifuge tube and 
defatted by centrifugation at 3,500 g for 20 min. After the fat was separated, the resulting 
skimmed milk was transferred into a 50-ml plastic syringe which was attached to an 
immunoaffinity column. The skimmed milk was allowed to flow into the column by gravity 
at a rate of 1 ml/min. The column was then washed with 20 ml of water. AFM1 was eluted 
with 1.25 ml of acetonitrile: methanol (3: 2), followed by 1.25 ml of HPLC water. A total 
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volume of 2.5 ml of eluate was filtered through a nylon filter (0.45 µm) and used for analysis 
of AFM1 using HPLC. All milk samples were analyzed in duplicate. 
The complete chromatographic system (Class-LC10; Shimadzu, Kyoto, Japan) consisted of a 
HPLC pump (model LC-10AD), an auto injector (model SIL-10A), a column oven (model 
CTO-10A), and a fluorescence detector (model RF-10AXL). The HPLC conditions for 
analysis of AFM1 were as follows: column – Spherisorb ODS-2; column temperature – 40°C; 
mobile phase – water: methanol: acetonitrile (57: 23: 20); flow rate – 1 ml/min; detector – 
fluorescence spectrophotometer (excitation 360 nm; emission 440 nm). 
The AOAC Official Method 986.16 for detection of aflatoxins M1 and M2 in fluid milk (Cunniff, 
1995) was performed to confirm the AFM1 analysis using the immunoaffinity column. In brief, 
an aliquot of fluid milk or reconstituted milk powder sample (20 ml) was mixed with 20 ml of 
hot water (80°C), and AFM1 was extracted using a C18 Sep-Pak column. AFM1 was eluted from 
the column with ether. The ether phase was then cleaned up using a silica gel 60 mini-column; 
AFM1 was eluted with a mixture of methylene chloride: ethanol (95: 5). The eluate was 
evaporated to dryness under nitrogen gas; the residue was then dissolved in 0.2 ml of  
n-hexane. To convert AFM1 to AFM2a, which has a higher extinction coefficient, the solution 
was derivatized with 0.2 ml of trifluoroacetic acid at 40°C and then evaporated to dryness 
under nitrogen gas. The residue was dissolved in 2 ml of water: acetonitrile (3: 1). The final 
solution was filtered through a nylon filter (0.45 µm) and used for analysis of AFM1 by HPLC. 
The HPLC conditions for analysis of AFM2a were as follows: column – Spherisorb ODS-2  
(5 m, 4.6  250 mm); mobile phase – water: acetonitrile: isopropanol (80: 12: 8); flow rate – 1 
ml/min; detector – fluorescence spectrophotometer (excitation 365 nm; emission 455 nm).  
A combination of the two methods was used to confirm the quantification of AFM1 extracted 
using the AflaM1TM immunoaffinity column. The eluate (2.5 ml) from the immunoaffinity 
column was evaporated under nitrogen gas to dryness. The residue was dissolved in 0.2 ml of 
n-hexane and was quantified as described in the AOAC Official Method 986.16, with the 
addition of 0.2 ml of trifluoroacetic acid.  
2.4 Determination of limit of quantification 
The limit of quantification (LOQ) for AFM1 was determined using the Q2B method of the U.S. 
Food and Drug Administration (U.S. FDA, 1996). Milk samples (50 ml) were fortified with 
standard AFM1 at concentrations of 0.0125, 0.025, 0.05, 0.25, and 0.5 µg/L; blank samples were 
not fortified with standard AFM1. Concentrations of AFM1 in fortified milk samples and blank 
samples were quantified as described in Extraction and Determintion of AFM1 using the 
AflaM1TM immunoaffinity column. Calibration curves (n = 12) were obtained by least-square 
linear regression analysis of the residual peak heights versus fortified AFM1 concentrations. 
The calculation for LOQ was based on the standard deviation of y-intercepts of linear 
regression analysis (σ) and the slope (S) using the equation LOQ = 10 σ/S. The LOQ of the 
method was 0.01 µg/L and the overall recovery across the five concentrations of fortified 
AFM1 was 85.6%. The precision of the method, expressed as %CV (coefficient of variation), 
ranged from 2.8 to 5.6%, as previously discussed by Ruangwises & Ruangwises (2009). 
2.5 Statistical analysis 
A randomized block experiment was used to assess the differences between AFM1 
concentrations. Duncan’s multiple comparison test was applied to obtain significance levels 
between the four types of milk samples (P < 0.05). SPSS Statistics version 17.0 for Windows 
was used for statistical analysis. 
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3. Results and discussion 
Concentrations of AFM1 extracted using an immunoaffinity column with HPLC 
quantification were comparable to those analyzed using AOAC Official Method 986.16, and 
also comparable to those obtained from a combination of the two methods (extraction with 
an immunoaffinity column, derivatization with trifluoroacetic acid, and quantification with 
HPLC). Comparative results for AFM1 concentrations in liquid milk and milk powder samples 
obtained from the three procedures are presented in Table 1. In this study, the average density 
of reconstituted milk powder and liquid milk samples was 1.03 ± 0.027 g/ml (n = 90), which 
was used for unit conversion. Concentrations and incidence of AFM1 in 450 milk samples are 
presented in Table 2. Of the 450 samples, 288 (64.0%) were found to be contaminated with 
AFM1 equal to or above the LOQ of 0.01 µg/L. The incidence of AFM1 in milk powder, 
school milk, commercial pasteurized milk, and UHT milk samples was 21.1% (19/90), 71.1% 
(128/180), 78.9% (71/90), and 77.8% (70/90), respectively. Average concentrations of AFM1 
found in the four types of milk samples were 0.004 ± 0.009, 0.035 ± 0.028, 0.048 ± 0.034, and 
0.045 ± 0.034 µg/L, respectively. In this study, statistical analysis showed that the average 
concentration of AFM1 in milk powder samples was significant lower than those found in 
the other three milk products. The average concentration of AFM1 in school milk samples 
was significantly lower than those found in the commercial pasteurized and UHT milk 
samples. Of the 19 positive milk powder samples, only 2 samples were contaminated with 
AFM1 above the EU limit for infant milk products of 0.025 µg/kg. For school milk, 
commercial pasteurized milk, and UHT milk samples, 68/180 (37.8%), 25/90 (27.8%), and 
29/90 (32.2%) samples, respectively, were contaminated with AFM1 within the EU limit of 
0.05 µg/kg. Concentrations of AFM1 found in all milk samples were within the U.S. 
regulatory limit of 0.5 µg/kg.  
 
Sample AFM1 concentration (µg/L) * 
AOAC Official
Method 986.16
Immunoaffinity
column + TFA
Immunoaffinity 
column 
 
 
Milk Powder (dilution 1:8)
 Sample A 0.021 0.024 0.026 
 Sample A + 0.05 µg/L AFM1 0.027 0.028 0.033 
 Sample A + 0.1 µg/L AFM1 0.119 0.120 0.125 
 Sample A + 0.25 µg/L AFM1 0.291 0.302 0.299 
 Sample B 0.046 0.047 0.042 
 Sample C 0.031 0.040 0.038 
 Sample D 0.022 0.028 0.023 
 
Liquid Milk 
 Sample 1 0.035 0.032 0.033 
 Sample 1 + 0.05 µg/L AFM1 0.079 0.078 0.076 
 Sample 1 + 0.1 µg/L AFM1 0.127 0.122 0.129 
 Sample 1 + 0.25 µg/L AFM1 0.246 0.247 0.244 
 Sample 2 0.062 0.060 0.065 
 Sample 3 0.040 0.043 0.039 
 Sample 4 0.089 0.085 0.091 
 
*All samples were analyzed in duplicate. 
Table 1. AFM1 concentrations in milk powder and liquid milk samples obtained from three 
procedures  
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Sample Samples
Positive 
(%) 
AFM1 concentration  
(μg/kg) AFM1 incidence1 
     
     
 Analyzed  Mean ± SD Range2 
0.010- 0.050 
μg/kg 
0.051- 0.075
 μg/kg 
0.076- 0.100 
μg/kg 
≥ 0.101 
μg/kg 
         
         
Milk powder 90 19 (21.1)3 0.004± 0.0094 A5 0.011-0.048 19 (21.1) - - - 
         
Liquid milk         
Pasteurized  
school milk 
180 128 (71.1) 0.035±0.028 B 0.012-0.104 68 (37.8) 50 (27.8) 7 (3.9) 3 (1.7) 
Pasteurized  
commercial 
90 71 (78.9) 0.048± 0.034 C 0.014-0.109 25 (27.8) 29 (32.2) 14 (15.6) 3 (3.3) 
UHT  
 commercial 
90 70 (77.8) 0.045± 0.034 C 0.012-0.112 29 (32.2) 26 (28.9) 11 (12.2) 4 (4.4) 
         
Overall 450 288 (64.0) 0.034± 0.031 0.011-0.112 141 (31.3) 105 (23.3) 32 (7.1) 10 (2.2) 
         
1AFM1 incidence of the positive samples 
2Ranges of AFM1 concentrations of the positive samples 
3Numbers in parentheses are percentages of each milk product 
4Concentrations of AFM1 in reconstituted milk powder samples (1: 8) 
5Different letters (A, B, C) denote significant differences between means of each milk product (P < 0.05) 
Table 2. Concentrations and incidence of AFM1 in milk powder and liquid milk samples 
 
Since each of the five Thai population groups consumed different types of milk products, 
calculation of the daily AFM1 intake for each population group was based on the mean AFM1 
concentrations in the corresponding milk products. The mean daily AFM1 intake  
by each group was calculated as follows: mean AFM1 intake (ng AFM1/day) = (mean daily 
milk intake, kg/day) x (mean AFM1 concentration in the corresponding milk products, 
µg/kg) x 1,000 (a unit conversion factor, ng/µg). The mean consumption amounts of milk 
products for the five Thai population groups were 0.429, 0.220, 0.138, 0.059, and 0.036 kg/day, 
respectively, while the average body weights were 10.1, 20.0, 46.2, 59.4, and 54.5 kg, 
respectively (National Bureau of Agricultural Commodity and Food Standards, 2006).  
For Group 1 (age range, 0–3 yr), a mean AFM1 concentration in milk powder samples of 
0.004 µg/kg (n = 90) was used for the calculation of daily AFM1 intake. A mean AFM1 
concentration of 0.024 µg/kg in milk powder and school milk samples (n = 270) was used 
for the calculation of daily AFM1 intake for Group 2 (>3–9 yr), while a mean AFM1 
concentration of 0.040 µg/kg in school milk, commercial pasteurized milk, and UHT milk 
samples (n = 360) was used for Group 3 (>9–19 yr). As school milk is consumed by students 
in Grades 1–6 (6–12 yr), concentrations of AFM1 in school milk samples were used for both 
Groups 2 and 3. For Group 4 (>19–65 yr) and Group 5 (>65 yr), a mean AFM1 concentration 
of 0.045 µg/kg in commercial pasteurized and UHT milk samples (n = 180) was used for the 
calculation of daily AFM1 intake. The estimated daily intakes of AFM1 for the five Thai 
population groups were 1.63, 5.29, 5.50, 2.63, and 1.62 ng/day, respectively. The estimated 
daily intakes of AFM1 with respect to body weight for the five population groups were 0.16, 
0.26, 0.12, 0.04, and 0.03 ng/kg BW/day, respectively.  
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Daily intakes of AFM1 in various regions and countries are presented in Table 3. The Joint 
FAO/WHO Expert Committee on Food Additives (JECFA) calculated that the daily AFM1 
intakes in Africa, the Middle East, Latin America, Europe, and the Far East (using the mean 
AFM1 concentrations in four different milk products) were 0.002, 0.005, 0.022, 0.023, and 0.36 
µg/kg, respectively (JECFA, 2001). The amounts of milk products consumed in the five regions 
were 0.042, 0.12, 0.16, 0.29, and 0.032 kg/day, respectively. The estimated intakes of AFM1 in the 
five regions were 0.1, 0.6, 3.5, 6.8, and 12 ng/day, respectively. When AFM1 intakes were 
calculated with respect to body weight (assuming 60 kg), the estimated daily intakes of AFM1 
were 0.002, 0.1, 0.058, 0.11, and 0.20 ng/kg BW/day, respectively (JECFA, 2001).  
 
     
Region/Country Milk  
consumption1 
AFM1  
concentration 
Daily AFM1 intake Reference 
   
     
 (kg/day) (µg/kg) ng/day ng/kg BW/day  
      
      
Africa 0.042 0.002 0.1 0.002 JECFA (2001) 
Middle East 0.12 0.005 0.6 0.1 JECFA (2001) 
Latin America 0.16 0.022 3.5 0.058 JECFA (2001) 
Europe 0.29 0.023 6.8 0.11 JECFA (2001) 
Far East 0.032 0.36 12 0.20 JECFA (2001) 
France  age 3-14 yr 0.312 0.005-0.052 NA3 0.22 
Leblanc  
et al. (2005) 
 age >15 yr 0.229 0.005-0.052 NA3 0.09  
      
Brazil children 0.3604 0.061 23.92 1.045 
Shundo  
et al. (2009) 
 adults 0.4124 0.031 11.28 0.1885  
      
Spain  age 4-9 yr 0.532 0.009696 2.63 0.21 
Cano-Sancho  
et al. (2010) 
 age 10-19 yr 0.404 0.00969 2.01 0.07  
 age 20-65 yr 0.305 0.00969 1.44 0.04  
 age >65yr 0.407 0.00969 1.94 0.05  
      
Thailand    age 0-3 yr 0.429 0.0047 1.63 0.16 This study 
 age >3- 9yr 0.220 0.0247 5.29 0.26  
 age >9-19 yr 0.138 0.0407 5.50 0.12  
 age >19-65 yr 0.059 0.0457 2.63 0.04  
 age >65yr 0.036 0.0457 1.62 0.03  
 Overall 0.176 0.0320 3.33 0.12  
      
1Average milk consumption for each region or country 
2AFM1 concentrations in five milk products which were used for the calculation of AFM1 intake for each 
population group (see text for details) 
3NA = Data not available 
4The values are average milk consumption amounts for both sexes calculated from milk consumption 
amounts by males and females in each of four population groups presented in the report 
5Daily AFM1 intakes were a summation of individual AFM1 intakes from five milk products 
6A single value of average AFM1 concentration in three milk products was used for the calculation of 
daily AFM1 intake for all four Spanish population groups 
7Average AFM1 concentrations in corresponding milk products for each Thai population group were 
used for the calculation of daily AFM1 intakes (see text for explanation) 
Table 3. Daily AFM1 intakes in various regions/countries 
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Leblanc et al. (2005) used individual means of AFM1 concentrations of five milk products – 
butter (0.05 µg/kg), desserts (0.05 µg/kg), cheeses (0.05 µg/kg), milk (0.005 µg/kg), and 
ultra-fresh dairy products (0.047 µg/kg) – and daily milk consumption to calculate daily 
AFM1 intakes for two French population groups: children (3–14 yr) and adults (≥ 15 yr). 
Daily intakes of AFM1 for each population group were the summation of daily AFM1 intakes 
from the five milk products; the estimated AFM1 intakes by French children and adults were 
0.22 and 0.09 ng/kg BW/day, respectively. Shundo et al. (2009) used AFM1 concentrations 
in different milk products to estimate daily AFM1 intake by Brazilian children and adults in 
the city of Sao Paulo. Based on the mean AFM1 concentration in powder milk samples (61 
ng/kg) collected from municipal day-care centers and elementary schools, an average milk 
consumption of 0.412 kg/day, and a body weight of 23 kg, the estimated daily AFM1 intake 
for children was 1.04 ng/kg BW. For adults, the estimated AFM1 intake was 0.188 ng/kg 
BW/day, which was calculated using the mean AFM1 concentrations in milk powder and 
fluid milk samples purchased from supermarkets (31 ng/kg), a daily milk consumption of 
0.361 kg, and a body weight of 60 kg. 
Cano-Sancho et al. (2010) used an average AFM1 concentration of 9.69 ± 2.07 ng/kg found in 
three milk products (UHT milk, cheese, and yogurt samples) to estimate daily AFM1 intake 
by four population groups in Catalonia, Spain. Average milk consumption for each of the 
four population groups – children (4–9 yr), teenagers (10–19 yr), adults (20–65 yr), and 
elderly (>65 yr) – was 0.532, 0.404, 0.305, and 0.407 kg/day, respectively; while the body 
weights were 26.2, 54.1, 73.7, and 73.3 kg, respectively. The estimated AFM1 intakes for the 
four Spanish population groups were 0.21, 0.07, 0.04, and 0.05 ng/kg BW/day, respectively.  
This study showed that 288 (64.0%) of the 450 milk samples collected from 45 provinces of 
Thailand were contaminated with AFM1 equal to or more than the LOQ of 0.01 µg/L. Daily 
intakes of AFM1 in five Thai population groups, calculated using corresponding AFM1 
concentrations in milk products consumed by each population group, were comparable to 
those of other regions and countries. Thai children (3–9 yr) had the highest AFM1 intake, 
0.26 ng/kg BW/day, which was comparable to those in the Far East (0.20 ng/kg BW/day), 
France (3–14 yr; 0.22 ng/kg BW/day), Brazil (adults, 0.188 ng/kg BW/day), and Spain (4–9 
yr, 0.21 ng/kg BW/day). Thailand is one of several countries that have not yet established 
regulatory limits for AFM1 in raw milk and milk products. The present study and our two 
previous reports (Ruangwises & Ruangwises, 2009, 2010) suggest regular monitoring of raw 
milk and milk products, and regulatory limits for AFM1 to ensure the quality of raw milk 
and milk products in Thailand.  
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